CN Patent

CN106511289A — 甲苯磺酸拉帕替尼片剂及其制备方法

Assigned to Hubei Co Ltd Of Bio-Pharmaceutical Industry Institute For Research And Technology · Expires 2017-03-22 · 9y expired

What this patent protects

本发明提供了甲苯磺酸拉帕替尼片剂及其制备方法，该片剂包括：甲苯磺酸拉帕替尼；以及预胶化淀粉。通过引入亲水性的预胶化淀粉，该片剂在pH1.0介质和pH6.8介质中的体外溶出行为均具有良好的一致性，且溶出过程不会出现结球成团现象，表现出良好的溶出效果和溶出一致性。

USPTO Abstract

本发明提供了甲苯磺酸拉帕替尼片剂及其制备方法，该片剂包括：甲苯磺酸拉帕替尼；以及预胶化淀粉。通过引入亲水性的预胶化淀粉，该片剂在pH1.0介质和pH6.8介质中的体外溶出行为均具有良好的一致性，且溶出过程不会出现结球成团现象，表现出良好的溶出效果和溶出一致性。

Drugs covered by this patent

Patent Metadata

Patent number
CN106511289A
Jurisdiction
CN
Classification
—
Expires
2017-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Hubei Co Ltd Of Bio-Pharmaceutical Industry Institute For Research And Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.